Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included but will usually appear in 24 hrs or less.

Rational Source
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. βœ… Go to Publication βœ…
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45
Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG ,
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. βœ… Go to Publication βœ…
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45
Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG ,
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. βœ… Go to Publication βœ…
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45
Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG ,
Membrane filter method to study the effects of Lactobacillus acidophilus and Bifidobacterium longum on fecal microbiota. βœ… Go to Publication βœ…
Microbiology and immunology (Microbiol Immunol ) Vol: 59 Issue 11 Pages: 643-52
Pub: 2015 Nov Epub: Authors Shimizu H , Benno Y ,
Membrane filter method to study the effects of Lactobacillus acidophilus and Bifidobacterium longum on fecal microbiota. βœ… Go to Publication βœ…
Microbiology and immunology (Microbiol Immunol ) Vol: 59 Issue 11 Pages: 643-52
Pub: 2015 Nov Epub: Authors Shimizu H , Benno Y ,
Additional sources and private correspondance βœ…
Private Correspondance (Private Correspondance ) Vol: 1 Issue Pages: 8-12
Pub: 2018 Epub:
Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis. βœ… Go to Publication βœ…
PloS one (PLoS One ) Vol: 12 Issue 4 Pages: e0175935
Pub: 2017 Epub: 2017 Apr 24 Authors Celiberto LS , Bedani R , Dejani NN , Ivo de Medeiros A , Sampaio Zuanon JA , Spolidorio LC , Tallarico Adorno MA , Amâncio Varesche MB , Carrilho Galvão F , Valentini SR , Font de Valdez G , Rossi EA , Cavallini DCU ,
Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats. βœ… Go to Publication βœ…
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 103 Issue 23-24 Pages: 9673-9686
Pub: 2019 Dec Epub: 2019 Nov 12 Authors Wang Q , Lv L , Jiang H , Wang K , Yan R , Li Y , Ye J , Wu J , Wang Q , Bian X , Yang L , Jiang X , Xie J , Lu Y , Shen J , Li L ,
Bifidobacterium longum subsp. longum BL21 Ameliorates Alcoholic Liver Disease in Mice Through Enhancement of the Hepatic Antioxidant Capacity and Modulation of the Gut Microbiota. βœ…
Journal of applied microbiology (J Appl Microbiol ) Vol: Issue Pages:
Pub: 2023 Oct 31 Epub: 2023 Oct 31 Authors Dong Y , Wu Z , Gai Z , Han M ,
Long-term intake of Lactobacillus helveticus enhances bioavailability of omega-3 fatty acids in the mouse retina. βœ… Go to Publication βœ…
NPJ biofilms and microbiomes (NPJ Biofilms Microbiomes ) Vol: 10 Issue 1 Pages: 4
Pub: 2024 Jan 18 Epub: 2024 Jan 18 Authors Lapaquette P , Terrat S , Proukhnitzky L , Martine L , Grégoire S , Buteau B , Cabaret S , Rieu A , Bermúdez-Humarán LG , Gabrielle PH , Creuzot-Garcher C , Berdeaux O , Acar N , Bringer MA ,
Long-term intake of Lactobacillus helveticus enhances bioavailability of omega-3 fatty acids in the mouse retina. βœ… Go to Publication βœ…
NPJ biofilms and microbiomes (NPJ Biofilms Microbiomes ) Vol: 10 Issue 1 Pages: 4
Pub: 2024 Jan 18 Epub: 2024 Jan 18 Authors Lapaquette P , Terrat S , Proukhnitzky L , Martine L , Grégoire S , Buteau B , Cabaret S , Rieu A , Bermúdez-Humarán LG , Gabrielle PH , Creuzot-Garcher C , Berdeaux O , Acar N , Bringer MA ,
Health-Promoting Properties of Lactobacillus helveticus. βœ… Go to Publication βœ…
Frontiers in microbiology (Front Microbiol ) Vol: 3 Issue Pages: 392
Pub: 2012 Epub: 2012 Nov 19 Authors Taverniti V , Guglielmetti S ,

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)